Soil Treatment Sample Clauses

Soil Treatment. An area of the north portion of Site #8 is present with fill material that exceeded the toxicity characteristic limit prescribed by CFR 261.24 and is considered a characteristically hazardous material. Further sampling in the area indicates that the area with elevated TCLP concentrations is limited to an approximately 3,200 square foot area surrounding test pits TP-3 and TP-6. The TCLP lead concentration in the surface interval of TP-14 also exceeded the TCLP threshold; however, this TCLP concentration appears to be anomalous – the total lead concentration in this sample was 2300 mg/kg. Four additional samples with equal or greater total lead concentrations ranging from 2300 mg/kg to 4600 mg/kg had TCLP concentrations below the threshold. A graphical representation of TCLP lead vs. total lead (provided in Appendix B) shows a very strong relationship, with TP-14 as the loan outlier. Terracon correlated on-site total lead and TCLP concentrations through a regression analysis and determined soils with total lead concentrations of 4,000 mg/kg or less are unlike to be characteristically hazardous. Therefore, soil and fill material with total lead concentrations greater than 4,000 mg/kg lead will be handled as characteristically hazardous material. Soil which exceeds the TCLP threshold for lead (see Figure 5) will be stockpiled, managed to control potential erosion while stockpile, and sampled. The soil to be placed in the stockpile will be homogenized to the extent possible via the excavation equipment. The stockpiled material will be screened against the threshold of 4,000 mg/kg discussed above. Verification samples will be collected at frequency of three (3) composite samples per 100 cubic yards of stockpiled material. The composite samples will consist of 5 to 7 grab aliquots from the portion of the stockpiled material. See Section 7.2.1 for further sampling details. Material exceeding this threshold will be treated with Blastox® 215 or similar to prevent lead migration. The lead stabilizer (Blastox 215 or equivalent) which will be mixed into the stockpiled soil in 1 to 3 foot lifts. The treated soil will be disposed of at the landfill, as feasible, as this soil represents the highest total lead detections on Site 8. Remaining soil will be placed on West Xxxxxxx Site #5 through #7 and will subsequently be covered with an exposure barrier. Bulk samples will be required to do an off site bench scale test to determine the appropriate treatment rate. Blastox tre...
Sample 1
AutoNDA by SimpleDocs
Soil Treatment. Our proposal includes but is not limited to 12" of crushed rock and 4 passes of water injection of the building pad in order to meet the geotechnical's recommendations for the slab and foundation design.
Sample 1
Soil Treatment. L. Treat soil with a termiticide adjacent to all foundation elements, pipes and other utility conduits both inside and outside the foundation wall.. (If slabs adjacent to the foundation wall prevent trenching, see "Slab Treatment J." above.) M. Trench and treat soil with a termiticide to a depth below and under the edge of stucco on wood or similar type material.
Sample 1

Related to Soil Treatment

  • Medical Treatment Undersigned understands that the Released Parties do not have medical personnel available at the location of the activities. Undersigned hereby grants the Released Parties permission to administer first aid or to authorize emergency medical treatment, if necessary. Undersigned understands and agrees that any such action by the Released Parties shall be subject to the terms of this agreement and release, including any liability arising from the negligence of the Released Parties when administering first aid or authorizing others to do so. Undersigned understands and agrees that the Released Parties do not assume responsibility for any injury or damage which might arise out of or in connection with such authorized emergency medical treatment.

  • Equal Treatment No consideration shall be offered or paid to any person to amend or consent to a waiver or modification of any provision of the Transaction Documents unless the same consideration is also offered and paid to all the Subscribers and their permitted successors and assigns.

  • National Treatment In the sectors inscribed in its Schedule, and subject to any conditions and qualifications set out therein, each Party shall accord to services and service suppliers of the other Party treatment no less favourable than that it accords, in like circumstances, to its own services and service suppliers.

  • Emergency Medical Treatment I grant the Releasees permission to authorize emergency medical treatment as they deem appropriate, and agree that such action by the Releasees shall be subject to the terms of this Agreement. I understand and agree that the Releasees assume no responsibility for any injury or damage that might result from such emergency medical treatment.

  • Xxx Treatment We have not promised you any particular tax outcome from buying or holding the Note.

  • National Treatment and Most-favoured-nation Treatment (1) Each Contracting Party shall accord to investments of investors of the other Contracting Party, treatment which shall not be less favourable than that accorded either to investments of its own or investments of investors of any third State. (2) In addition, each Contracting Party shall accord to investors of the other Contracting Party, including in respect of returns on their investments, treatment which shall not be less favourable than that accorded to investors of any third State. (3) The provisions of paragraphs (1) and (2) above shall not be construed so as to oblige one Contracting Party to extend to the investors of the other the benefit of any treatment, preference or privilege resulting from: (a) Any existing or future free trade area, customs unions, monetary union or similar international agreement or other forms of regional cooperation to which one of the Contracting Parties is or may become a party, or (b) Any matter pertaining wholly or mainly to taxation.

  • Confidential Treatment The parties hereto understand that any information or recommendation supplied by the Sub-Adviser in connection with the performance of its obligations hereunder is to be regarded as confidential and for use only by the Investment Manager, the Company or such persons the Investment Manager may designate in connection with the Fund. The parties also understand that any information supplied to the Sub-Adviser in connection with the performance of its obligations hereunder, particularly, but not limited to, any list of securities which may not be bought or sold for the Fund, is to be regarded as confidential and for use only by the Sub-Adviser in connection with its obligation to provide investment advice and other services to the Fund.

  • Equal Treatment of Purchasers No consideration (including any modification of any Transaction Document) shall be offered or paid to any Person to amend or consent to a waiver or modification of any provision of the Transaction Documents unless the same consideration is also offered to all of the parties to the Transaction Documents. For clarification purposes, this provision constitutes a separate right granted to each Purchaser by the Company and negotiated separately by each Purchaser, and is intended for the Company to treat the Purchasers as a class and shall not in any way be construed as the Purchasers acting in concert or as a group with respect to the purchase, disposition or voting of Securities or otherwise.

  • Equal Treatment of Investors No consideration shall be offered or paid to any Person to amend or consent to a waiver or modification of any provision of any of the Transaction Documents unless the same consideration is also offered to all of the parties to the Transaction Documents. For clarification purposes, this provision constitutes a separate right granted to each Investor by the Company and negotiated separately by each Investor, and is intended for the Company to treat the Investors as a class and shall not in any way be construed as the Investors acting in concert or as a group with respect to the purchase, disposition or voting of Securities or otherwise.

  • Sale Treatment The Company has determined that the disposition of the Mortgage Loans pursuant to this Agreement will be afforded sale treatment for accounting and tax purposes;

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!